Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)

Yi Min Liu; Wei Chun HuangFu; Han Li Huang; Wei Cheng Wu; Yi Lin Chen; Yun Yen; Hsiang Ling Huang; Chih Ying Nien; Mei Jung Lai; Shiow Lin Pan; Jing Ping Liou

doi:10.1016/j.ejmech.2020.112633

Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)

Yi Min Liu, Wei Chun HuangFu, Han Li Huang, Wei Cheng Wu, Yi Lin Chen, Yun Yen, Hsiang Ling Huang, Chih Ying Nien, Mei Jung Lai, Shiow Lin Pan, Jing Ping Liou

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

1 引文斯高帕斯（Scopus）

摘要

The authors regret that the information of concentration unit of the Table 2 and 3 and the name of synthesized compound 10e in 4.1.1.5 was incorrect. The correct version should be: The concentration unit of the Table 2 and 3 is μM. The name of synthesized compound 10e is 4-(((3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)methyl)-N-(pyridin-4-yl)benzamide (10e) in 4.1.1.5. The authors would like to apologise for any inconvenience caused.

原文	英語
文章編號	112633
期刊	European Journal of Medicinal Chemistry
卷	202
DOIs	https://doi.org/10.1016/j.ejmech.2020.112633
出版狀態	已發佈 - 9月 15 2020

ASJC Scopus subject areas

藥理
藥物發現
有機化學

存取文件

10.1016/j.ejmech.2020.112633

其它文件與鏈接

Link to publication in Scopus

指紋

深入研究「Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)」主題。共同形成了獨特的指紋。

引用此

Liu, Y. M., HuangFu, W. C., Huang, H. L., Wu, W. C., Chen, Y. L., Yen, Y., Huang, H. L., Nien, C. Y., Lai, M. J., Pan, S. L., & Liou, J. P. (2020). Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011). European Journal of Medicinal Chemistry, 202, 文章 112633. https://doi.org/10.1016/j.ejmech.2020.112633

Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011). / Liu, Yi Min ; HuangFu, Wei Chun; Huang, Han Li 等.
於: European Journal of Medicinal Chemistry, 卷 202, 112633, 15.09.2020.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Liu, YM , HuangFu, WC, Huang, HL, Wu, WC, Chen, YL, Yen, Y, Huang, HL, Nien, CY, Lai, MJ , Pan, SL & Liou, JP 2020, 'Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)', European Journal of Medicinal Chemistry, 卷 202, 112633. https://doi.org/10.1016/j.ejmech.2020.112633

Liu YM , HuangFu WC, Huang HL, Wu WC, Chen YL, Yen Y 等. Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011). European Journal of Medicinal Chemistry. 2020 9月 15;202:112633. doi: 10.1016/j.ejmech.2020.112633

@article{e64f9af6878947cdaafc6b7c9adff590,

title = "Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)",

abstract = "The authors regret that the information of concentration unit of the Table 2 and 3 and the name of synthesized compound 10e in 4.1.1.5 was incorrect. The correct version should be: The concentration unit of the Table 2 and 3 is μM. The name of synthesized compound 10e is 4-(((3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)methyl)-N-(pyridin-4-yl)benzamide (10e) in 4.1.1.5. The authors would like to apologise for any inconvenience caused.",

author = "Liu, {Yi Min} and HuangFu, {Wei Chun} and Huang, {Han Li} and Wu, {Wei Cheng} and Chen, {Yi Lin} and Yun Yen and Huang, {Hsiang Ling} and Nien, {Chih Ying} and Lai, {Mei Jung} and Pan, {Shiow Lin} and Liou, {Jing Ping}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Masson SAS",

year = "2020",

month = sep,

day = "15",

doi = "10.1016/j.ejmech.2020.112633",

language = "English",

volume = "202",

journal = "European Journal of Medicinal Chemistry",

issn = "0223-5234",

publisher = "Elsevier Masson SAS",

}

TY - JOUR

T1 - Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)

AU - Liu, Yi Min

AU - HuangFu, Wei Chun

AU - Huang, Han Li

AU - Wu, Wei Cheng

AU - Chen, Yi Lin

AU - Yen, Yun

AU - Huang, Hsiang Ling

AU - Nien, Chih Ying

AU - Lai, Mei Jung

AU - Pan, Shiow Lin

AU - Liou, Jing Ping

PY - 2020/9/15

Y1 - 2020/9/15

N2 - The authors regret that the information of concentration unit of the Table 2 and 3 and the name of synthesized compound 10e in 4.1.1.5 was incorrect. The correct version should be: The concentration unit of the Table 2 and 3 is μM. The name of synthesized compound 10e is 4-(((3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)methyl)-N-(pyridin-4-yl)benzamide (10e) in 4.1.1.5. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that the information of concentration unit of the Table 2 and 3 and the name of synthesized compound 10e in 4.1.1.5 was incorrect. The correct version should be: The concentration unit of the Table 2 and 3 is μM. The name of synthesized compound 10e is 4-(((3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)methyl)-N-(pyridin-4-yl)benzamide (10e) in 4.1.1.5. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85088017535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088017535&partnerID=8YFLogxK

U2 - 10.1016/j.ejmech.2020.112633

DO - 10.1016/j.ejmech.2020.112633

M3 - Comment/debate

C2 - 32688164

AN - SCOPUS:85088017535

SN - 0223-5234

VL - 202

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

M1 - 112633

ER -